Geistlich Pharma Australia and New Zealand Pty Ltd has been appointed as the exclusive distributor of TRI® Dental Implants across Australia and New Zealand.
This exciting development brings together two leading Swiss companies - Geistlich and TRI Dental Implants - each globally recognised for their unwavering commitment to innovation, clinical excellence and exceptional customer support. By combining TRI's state-of-the-art implant technology with Geistlich's strong foundation of scientific excellence, clinical credibility and regenerative expertise, the partnership aims to deliver a more integrated and streamlined experience for customers.
"TRI Dental Implants represent the future direction of dental implant technology," said Andrew Holmes, CEO of TRI Dental ANZ. "By engineering away the need for a separate abutment, not only is the cost of treatment reduced, but also cement can be completely removed from the process, lessening the chance of peri-implant disease developing in the future."
The TRI Matrix system eliminates the abutment by designing the restoration to be directly screwed into the implant's interface using a special bolt screw that carries the mechanical load. This is made possible by advancements in CAD/CAM technology which allows for the creation of a custom-fitted, one-piece restoration that bypasses the traditional abutment and cementation steps.
"Ever so slowly, the world is falling in love with TRI's Matrix implant for everything from single tooth to full arch restorations through its completely digital workflows," Mr Holmes said. "We believe the appointment of Geistlich as the distributor in ANZ will hasten the transition to this innovative digital implant system.
"We would like to take this opportunity to sincerely thank all TRI® users for your continued trust and loyalty over the years. Your support has played an important role in the success and growth of the TRI® brand in this region.
"As we embark on this new chapter together, you can be assured that the personalised service and product excellence you've come to expect will not only continue — but be further strengthened by the support of Geistlich's experienced and dedicated team."
From regenerative biomaterials to implant solutions and surgical care, Geistlich is proud to be the trusted partner in delivering quality outcomes for patients across Australia and New Zealand.
Wednesday, 28 January, 2026